14.55

0.97% 0.14

Embecta Corp (EMBC)

Overview News Price History Option Chain Financials Discussions Forecast Dividend History

Embecta Corp stock is traded at $14.55, with a volume of 299.48K. It is up +0.97% in the last 24 hours and up +7.54% over the past month. Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.

Previous Close:

$14.41

Open:

$14.3

24h Volume:

299.48K

Relative Volume:

0.70

Market Cap:

$850.96M

Revenue:

$1.10B

Net Income/Loss:

$83.60M

P/E Ratio:

10.17

EPS:

1.43

Net Cash Flow:

$132.30M

1W Performance:

+5.51%

1M Performance:

+7.54%

6M Performance:

+25.54%

1Y Performance:

-3.32%

1-Day Range:

$14.07

$14.59

1-Week Range:

$13.56

$14.91

52-Week Range:

$9.20

$21.48

Embecta Corp Stock (EMBC) Company Profile

Name

Embecta Corp

Sector

Healthcare (1135)

Industry

Medical Instruments & Supplies (58)

Phone

(862) 401-0000

Address

1209 ORANGE STREET, WILMINGTON

Employee

2,100

Twitter

Next Earnings Date

2025-08-08

Latest SEC Filings

EMBC's Discussions on Twitter

Compare EMBC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
EMBC Embecta Corp	14.55	842.77M	1.10B	83.60M	132.30M	1.43
ISRG Intuitive Surgical Inc	549.51	200.47B	9.61B	2.77B	2.27B	7.555
BDX Becton Dickinson Co	193.04	55.33B	21.84B	1.68B	2.67B	5.8322
ALC Alcon Inc	77.65	38.61B	10.19B	1.05B	1.39B	2.1065
RMD Resmed Inc	244.46	36.80B	5.26B	1.44B	1.76B	9.7713
WST West Pharmaceutical Services Inc	261.36	19.18B	2.96B	487.70M	344.00M	6.6758

Embecta Corp Stock (EMBC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Apr-10-25	Initiated	Mizuho	Neutral
Dec-02-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-27-24	Upgrade	BTIG Research	Neutral → Buy
Oct-20-23	Initiated	Wolfe Research	Peer Perform
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Sep-08-22	Initiated	BTIG Research	Neutral
Aug-01-22	Initiated	Morgan Stanley	Equal-Weight
Jun-21-22	Initiated	BofA Securities	Underperform

View All

Embecta Corp Stock (EMBC) Latest News

Nov 14, 2025

What the charts say about Embecta Corp. today2025 Geopolitical Influence & Long Hold Capital Preservation Tips - newser.com

Nov 14, 2025

Is a relief rally coming for Embecta Corp. holdersOptions Play & Free Expert Verified Stock Movement Alerts - newser.com

Nov 14, 2025

Embecta expands partnership with Direct Relief to support diabetes initiatives on World Diabetes Day - Drug Delivery Business

Nov 14, 2025

Why hedge funds are buying Embecta Corp. stockMarket Risk Analysis & Growth Focused Entry Reports - newser.com

Nov 14, 2025

Embecta Expands Partnership With Direct Relief to Support Global Diabetes Care - MarketScreener

Nov 14, 2025

embecta Announces Major New Commitment to Direct Relief on World Diabetes Day - The Manila Times

Nov 14, 2025

embecta Corp. Expands Partnership with Direct Relief to Enhance Access to Diabetes Supplies on World Diabetes Day - Quiver Quantitative

Nov 14, 2025

embecta (NASDAQ: EMBC) expands Direct Relief partnership to supply 15M diabetes devices - Stock Titan

Nov 14, 2025

Is Embecta Corp. stock a safe buy before earningsWeekly Gains Summary & Technical Buy Zone Confirmations - newser.com

Nov 14, 2025

Nov 13, 2025